PPT-Methodological challenges of studying CIPN during chemotherapy

March 23 2017 Jennifer Gewandter PhD MPH Presentation objectives Outline the design challenges and issues to consider when designing a CIPN study during chemotherapy Summarize how published RCTs have addressed these design challenges. Back Florian Bischoff, Hans-Peter B Methodology Milestone. Where are we heading? - 1. Better methods for . Capturing Complexity of Review Questions. Increased use of . Models, Theories & Frameworks. Greater Specification . and . Further Adaptation . Methodology Milestone. Where are we heading? - 1. Better methods for . Capturing Complexity of Review Questions. Increased use of . Models, Theories & Frameworks. Greater Specification . and . Further Adaptation . Themes in Psychology. Snapshot Study. Snapshot study. : takes place at just one point in time, potentially with one participant for a short time. It is aimed at isolating the . behaviour. and not necessarily with identifying a cause.. Investor Deck. April 2016. CAUTION REGARDING FORWARD-LOOKING STATEMENTS . . . This Presentation contains forward-looking statements and forward-looking information. Often, but not always, forward-looking statements can be identified by the use of words such as . 2. nd. Meeting. –. 15 09 2015. Venue: . Vienna. Boris Le Hir, Pierre Le Mouël & Paul Zagamé. , . Seureco. Methodological debriefing. Hierarchy of commitments regarding their relevance to be implemented in . Paradigms Script Pope SP201For educational purposes only do not redistributeMethodological ParadigmsGreetings Dr Elizabeth Pope here This screencast will introduce you to the concept of a methodologic You . Peter Argenta, MD. Definition. The conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased.. What does it mean for patients?. Head, Palliative Care Research. Division of Cancer Prevention. NCI: Programmatic Overview of CIPN Portfolio. . March. , 2017. Objectives. Provide an overview of the NCI Community Oncology Research Program (NCORP). Jessica Latchman APRN, AGACNP-BC AOCNP, ACHPN. Ann Guastella, APRN, AOCN, ACHPN. December 13, 2022. INTRODUCTION . Chemotherapy induced peripheral Neuropathy is common problem facing cancer patients . Lynn Howie, MD, Medical Officer, DOP1. Supportive Care is Crucial for . Cancer Treatment. Antiemetics. Growth factors. Bone health agents. Agents to reduce mucositis. Anti-diarrheals. Supportive care therapies reduce symptoms and side effects allowing for improved delivery of chemotherapy agents, many of which are given with curative intent . over 55 years of neuropathic toxicity: . if not now, when do we take . aaacttion. . Joanna M . Brell. , MD. Clinical Associate Professor of medicine. Case Western Reserve University. Associate Director Cancer Center for clinical research. Pamela Horn, MD. Clinical Reviewer. DAAAP. Outline. Patient Perspective from PFDD Public Meeting. Drug Approval Standards. Approved Therapies. Possible CIPN Indications. FDA Review Division Roles. Study Design Issues Raised by Sponsors. n. ges in Clinical . T. rials for CIPN. Michael P. McDermott, Ph.D.. University of Rochester Medical Center. Measurement of outcome. Strategies for statistical analysis. Defining the study population.